These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A Novel Spiro[acridine-9,9'-fluorene] Derivatives Containing Phenanthroimidazole Moiety for Deep-Blue OLED Application.
    Author: Sun W, Zhou N, Xiao Y, Wang S, Li X.
    Journal: Chem Asian J; 2017 Dec 05; 12(23):3069-3076. PubMed ID: 28984424.
    Abstract:
    Typical π-π stacking and aggregation-caused quenching could be suppressed in the film-state by the spiro conformation molecular design in the field of organic light-emitting diodes (OLEDs). Herein, a novel deep-blue fluorescent material with spiro conformation, 1-(4-(tert-butyl)phenyl)-2-(4-(10-phenyl-10H-spiro[acridine-9,9'-fluoren]-2-yl)phenyl)-1H-phenanthro[9,10-d]imidazole (SAF-BPI), was designed and synthesized. The compound consists of spiro-acridine-fluorene (SAF) as donor part and phenanthroimidazole (BPI) as acceptor part. Owing to the rigid SAF skeleton, this compound exhibits a high thermal stability with a glass transition temperature (Tg ) of 198 °C. The compound exhibits bipolar transporting characteristics demonstrated by the single-carrier devices. The non-doped OLEDs based on the SAF-BPI as the emitting layer shows maximum emission at 448 nm, maximum luminance of 2122 cd m-2 , maximum current efficiency (CE) of 3.97 cd A-1 , and a maximum power efficiency of 2.08 lm W-1 . The chromaticity coordinate is stable at (0.15, 0.10) at the voltage of 7-11 V. The device shows a slow efficiency roll-off with CE of 3.35 and 2.85 cd A-1 at 100 and 1000 cd m-2 , respectively.
    [Abstract] [Full Text] [Related] [New Search]